Maxime Fredon
Besancon, 25000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Metformin dual-targets metabolism and survival pathways in BPDCN.
Journal: iScience
Published: July 30, 2025
Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.
Journal: Haematologica
Published: July 10, 2025
Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.
Journal: Molecular therapy. Oncology
Published: June 13, 2025
Venetoclax in the Therapeutic Strategy for BPDCN Management.
Journal: EJHaem
Published: January 09, 2025
New leads to enhance tagraxofusp efficacy in pDC-AML.
Journal: Blood neoplasia
Published: October 28, 2024
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.
Journal: Cancer immunology research
Published: February 28, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.
Journal: Cancer immunology research
Published: July 10, 2023
Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma.
Journal: Cells
Published: April 07, 2023
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells.
Journal: Cancers
Published: May 20, 2022
Last Updated: 09/26/2026